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THE BIO-ASSAY OF P3-ESTRADIOL*
S. A. THAYER, E. A. DOISY, JR., AND EDWARD A. DOISY
Occasionally, a scientist makes a discovery which stands out
clearly as the contribution which has had a profound effect on the
subsequent developments and advance in a particular field of science.
That Edgar Allen's introduction of the vaginal smear method' for
detection of the "ovarian follicular hormone" was such a discovery
isevidencedbythetremendous advances in ourknowledge of ovarian
physiology and in the chemical study of the estrogens resulting from
the application of his method. Allen's contribution was the base
upon which many subsequent investigations in all parts of the world
were founded.
Although Allen's original procedure has been modified in many
respects, still the basic principle remains unchanged. Nearly every
investigator in the estrogen field has developed his own modifications
of assay technic. In this laboratory five different procedures have
been used for many years in the study of the activity of estrogens.
This report deals in part with the potencies ofP3-estradiol,P-estradiol-
3-benzoate, estrone, and a-estradiol as determined by these technics.
P-Estradiiol was first obtained by Schwenk and Hildebrandt"5 by
catalytic reduction of estrone. Subsequently, Butenandt and
Goergens2 and Wintersteiner et al.'8 reported more details on its
preparation, chemical and physical properties, and potency, and
Wintersteiner and Hirschmann'7 reported its isolation from the
urine of pregnant mares. More recently, Stroud,'6 Fish and Dorf-
man,8 Heard et al.,9 and Pearlman and Pearlman"3 have shown that
P-estradiol is an important metabolite of a-estradiol and estrone in
certain species of laboratory animals.
Our interest in the metabolism of estrogens has led us (Doisy,
Thayer, and Van Bruggen0) to a study of the products of excretion
following the administration ofP-estradiol to a monkey. An increase
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in the estriol, estrone, and estradiol fractions occurred. In an
attempt to ascertain the nature of the estradiol fraction a differential
assay which was based on the data submitted in this paper was
employed; the results indicated that the estradiol fraction contained
a non-ketonic estrogen which was more active than was ,3-estradiol.
Pearlman and Pincus14 have subsequently contributed another pro-
cedure for the characterization of the weak-phenolic non-ketonic
fraction which is based on the alteration of potency caused by the
oxidation of the 17-hydroxyl with aluminum tert-butoxide.
Since the bio-assay of ,-estradiol showed this compound to have
very low estrogenic activity, and metabolism studies as well as theo-
retical considerations indicated the possibility of the conversion of
c3-estradiol to estrone and a-estradiol, it seemedpossible that ,-estra-
diol might owe its estrogenic property to compounds produced by its
metabolism, i.e., it might be a pro-estrogen. Consequently, it was
subjected to the procedure used by Emmens7 for differentiating
estrogens and pro-estrogens. Data in the experimental section
clearly indicate that P-estradiol conforms to Emmens's description of
the behavior of a true estrogen in that vaginal cornification is pro-
duced byvaginal application of only a minute fraction of the amount
required when administered subcutaneously.
Experimental
Preparation and Characterization of P-Estradiol: The P-estradiol*
used in our experiments was obtained by purification of the phenolic
non-ketonic fraction of an extract of mare's urine by adsorption on a
column of Merck's alumina. Petroleum ether containing ethyl
alcohol was used for elution. Subsequent purification of the frac-
tionshavingaspecific rotation less than +600 was effectedby recrys-
tallization from aqueous ethyl alcohol and from acetone until the
melting-point remained constant.
Since the potency of cx-estradiol is so much greater than is that
of 3-estradiol, contamination of the latter with even a small quantity
*The ,-estradiol was,prepared from a light-colored partially purified residue
from the commercial production of estrone which was obtained from Eli Lilly and
Co. We wish to express our appreciation to Mr. George B. Walden for this
material.
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of the former would lead to markedly erroneous values for bio-
assay. Consequently, the ,-estradiol was carefully purified and
characterized.
,8-Estradiol: M.P. 222-2230 (corr.)-no depression of melting-point
when mixed with 3-estradiol prepared by reduction of estrone.
[25a = + 52.20 (dioxane)
C H
Analysis: C18H2402 Calculated: 79.35 8.89
Found: 79.10 8.63
79.24 8.89
The benzoate and acetate were made for characterization of
,-estradiol. The melting-point of the diacetate agrees with the
values reported by Butenandt2 and by Whitman et al."8 Crystal-
lized from aqueous acetone, our product did not contain solvent of
crystallization.
3-Estradioldiacetate: M.P. 139.5-140° (corr.).
C H
Analysis: C22H2804 Calculated: 74.12 7.92
Found: 74.01 8.05
74.13 8.19
Our experiments with the monobenzoate gave data which indi-
cate that this compound may exist in different crystalline modifica-
tions having different melting-points and consequently the melting-
point of the benzoate is not entirely satisfactory for identification
purposes. (In this connection see Hirschmann and Wintersteiner."7)
In addition to the platelet form observed by Butenandt2 and by
Whitman et al.,18 we have frequently obtained the compound in
long needles, and also in a mixture of needles and plates. Occasion-
ally upon recrystallization of an analytically pure sample from puri-
fied solvents the melting-point decreased several degrees. Further-
more, although we have obtained the benzoate from aqueous methyl
alcohol containing 0.5 mole of solvent of crystallization (the form
reported by Butenandt), usually the compound did not contain
solvent of crystallization.
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,3-Estradiol-3-benzoate: M.P. 153.5-154.5° (corr.).
C H
Analysis: C25H2803 Calculated: 79.74 7.50
Found: 79.89 7.81
79.55 7.68
Assay of @-Estradiol: The assay of @-estradiol was conducted by the
procedures which were used in the study of a-estradiol which had
been isolated from liquor folliculi.10 Although the methods were
described briefly in our earlier publication, a slight degree of repeti-
tion is introduced in this paper to aid the reader.
Modified Butenandt Procedure;3 10 A Single Injection of Estrogen
in Oil; Mice: Mice were ovariectomized as previously described by
Allen and Doisy.' Vaginal smears were made daily for a period of
two weeks following ovariectomy and animals that did not show a
negative smear each day were discarded. Two weeks after ovari-
ectomy, the mice were primed with an aqueous solution of estrone
containing 0.1 y or one international unit. Smears were taken at
9:00 A. M.) 1:00 P. M., and 5:00 P. M. starting 48 hours after the
injection.
One week after priming, the mice were divided into two groups
of 20 animals. Each of one group of 20 animals was injected sub-
cutaneously at 9:00 A. M. with the oily preparation being tested; each
of a similar group was injected with the standard estrone preparation
dissolved in oil, and the proportion of positive effects in each group
was determined. After one or two trial experiments, the dosages
could usually be so adjusted that approximately the same percentage
responses to the unknown and standard were obtained. In accord-
ance with the work of Coward and Burn4 a 50 per cent positive
response was regarded as one unit; the unknown was evaluated in
terms of the standard response curve and the concurrent response to
the standard.
Mice that failed to respond positively to an injection within 80
hours were immediately primed with an oily solution containing
0.05 y of estrone. Owing to the slow rate of absorption mice were
not used again until four weeks had elapsed following a positive
response. The volume of oil injected was usually 0.2 cc. and in
all experiments the unknown and standard were administered in the
same volume.
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Mather Modification of the Marrian-Parkes Proced-ure;11 12 Four
Injections of an Aqueous Solution; Mice: Ovariectomized mice were
given subcutaneous injections of four equal quantities of an aqueous
solution at 8:00 A. M. and 5:00 P.M. on two consecutive days.
Smears were taken at 9:00 A. M. and 5:00 P. M., starting 16 hours
after the last injection, and the last smear was taken 48 hours after
the first smear. In this method the same principles were followed
as in the modified Butenandt method, using comparable animals and
the same method of determining potency of a preparation. The
estrogens and the standard preparation used in this assay procedure
were dissolved in an aqueous medium. Animals that showed a
negative response from previous injections were primed with an
aqueous solution containing 0.1 y of estrone before they were used
for another assay. In this method the test animals were used every
two weeks.
Thayer-Doisy Procedure; Three Injections of an Aqueous Solu-
tion; Mice: Injections were made at 9:00 A. M., 1:00 P. M., and
5:00 P. M. on the same day. The same principles regarding prim-
ing, estimation of activity, etc. which were used in the preceding
method were followed in this procedure, with the exception that the
mice were used for assay at intervals of seven days. We have used
this method for many years as a routine procedure to determine the
biological activity of estrogens.
Allen-Doisy Procedure;' Three Injections of an Aqueous Solution;
Rats: Ovariectomized rats were given subcutaneous injections of
three equal quantities of an aqueous solution at intervals of four and
one-half hours. All rats used had given a positive response one
week before use for assay due to priming with 1.2 y of estrone or a
previous assay. The same principles were followed as in the other
procedures for determination of units. In this method the changes
of the cells in the vagina may be regarded as positive if a few
leukocytes are present along with the nucleated epithelial cells and
squamous non-nucleated epithelial cells.
Curtis-Doisy Procedure;5 Six Injections of Aqueous Solution;
Immature Rats: The estrogen was injected at 9:00 A. M. and 5:00
P. M. on three successive days. Changes in the procedure from the
original method as published by Curtis and Doisy were: the require-
men-t of opening of the vagina with a positive smear, and application
of the same procedure for determination of units as in the other assay
methods.
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The results obtained from using these five different assay pro-
cedures are given in table 1.
TABLE 1
POTENCIES OF f.-ESTRADIOL, ,B-ESTRADIOL MONOBENZOATE, a-ESTRADIOL AND
ESTRONE AS DETERMINED BY FIVE DIFFERENT METHODS OF BIO-ASSAY
Butenandt Marrian-Parkes Allen-Doisy Curtis-Doisy
modified modified Thayer-Doisy modified modified
Compounds units/mg. units/mg. units/mg. units/mg. uits/mg.
/3-Estradiol 700 8,000 2,000 200 700
a-Estradiol 35,000 70,000 40,000 17,000 5,000
Estrone 20,000 35,000 20,000 1,700 1,000
fl-Estradiol
benzoate 1,000 2,400 450 200 200
Rl 28 4.4 10 8.5 1.4
R2 1.4 0.3 0.22 1. 0.3
R1 _ Potency Of estrone R2 _ Potencyof./-estradiol-3-benzoate
Potency offl-estradiol Potency offl-estradiol
Ratio of Estrogenic Potencies by Systemic and Local Admi#istra-
tioiz: In order that our data might be comparable to those published
by Emmens,7 the systemic mouse unit for ~-estradiol was determined
on a group of mice injected at 9:00 A. M. on each of two consecutive
days with one-half of the total dosage of oily preparation. Smears
were taken on the third and fourth days. The systemic mouse unit
was 1.65 y or 600 units per milligram.
Emmens's procedure was also used to determine the local unit,
i.e., the amount required by local application to the vagina to pro-
duce cornification in that tissue. Sixty-two per cent of 29 mice
responded to the administration of 0.033 y with cornified smears.
This gives a S/L ratio 1.65 = 50, the same value reported by 0.033
Emmens for estradiol, presumably a-estradiol in view of the values
of the systemic and local units given, respectively, 0.025 y and
0.0005 y.
Discussion
Butenandt's data2 indicate that estrone is approximately 37 times
as potent as is ,3-estradiol, while our figures obtained by Butenandt's
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assay procedure show the ratio of potencies to be 28. The compari-
son of potencies published by Hirschmann and Wintersteiner" was
based on assays in which rats were injected with a solution of estro-
gen in oil and therefore is not directly comparable with our assay in
mature rats. Pearlman and Pincus1' have also used rats in an assay
procedure differing somewhat from ours. Nevertheless, the ratios
which are respectively 13, 12, and 8.5 show an acceptable agreement.
In our work, in which various procedures were used, the ratios of
potencies varied from 28 to 1.4. Apparently, the potency of
3-estradiol with respect to estrone is improved by divided dosage and
the greatest division of dosage gives the highest potency for ,-estra-
diol in relation to estrone. Furthermore, the lowest relative potency
was found with the method (Butenandt) using a single injection of
mice with an oily preparation.
The comparison of potencies of ~-estradiol and its benzoate
yields some rather astonishing figures. The potency of the benzoate
ranges from 1.4 times to 0.22 of the potency of 3-estradiol, depend-
ing upon the method of assay.
Perhaps, the most apparent conclusion is that the potency of an
estrogen depends to a great extent on the method used for assay and
that it is necessary for the accurate comparison of potencies of two
compounds that they be assayed by exactly the same procedure.
Summary
1. P-Estradiol has been prepared from mare urine and charac-
terized by its physical constants and the preparation of derivatives.
2. ,3-Estradiol and ,B-estradiol-3-benzoate have been assayed by
five procedures in use in this laboratory. A comparison of the
potencies of these compounds and of ,3-estradiol and estrone shows
that the relative activities depend in part on the method of assay.
3. Determination of the potencies by subcutaneous administra-
tion and by local application to the vagina shows that ,-estradiol is
a true estrogen.
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